Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02301351 · ClinicalTrials.gov registry record · NA
Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
NCT02301351: Completed NA study, sponsored by University of Pennsylvania.
NCT02301351 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 316 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02301351, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of changes in cigarette package color and warning label features on smoking behaviors and beliefs about cigarette risks.
Primary Outcome
Daily cigarette consumption will be determined by the difference of unused cigarettes and used cigarette filters returned to the Center every Session after Day 0.The number of used cigarette filters and self-reported daily smoking rate will be recorded on a Smoking Rate Data Collection Form. We will examine changes in daily cigarette consumption averaged over each of the three 15-day pack periods.
Interventions
- OTHER Graphic Warning Label
- OTHER Text Warning Label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2014-10 |
| Est. Completion | 2019-04-12 |
| Phase | NA |
What the finished NCT02301351 record still lists
NCT02301351 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Graphic Warning Label is the first listed.
NCT02301351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02301351 about?
NCT02301351 is a clinical study titled "Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors". The purpose of this study is to examine the effect of changes in cigarette package color and warning label features on smoking behaviors and beliefs about cigarette risks.
What is the current status of trial NCT02301351?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2014-10. Estimated completion is 2019-04-12.
What interventions are being tested in trial NCT02301351?
The interventions under investigation include: Graphic Warning Label (OTHER), Text Warning Label (OTHER).
Who is sponsoring clinical trial NCT02301351?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02301351's enrollment target sits among peer trials
316 321st of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia